A New Office Based Protocol to Reverse AGA Miniaturization at Early and Advanced Stages

The study tested a new treatment protocol for Androgenetic Alopecia (AGA) on 40 patients, using a combination of autologous regenerative therapy, mesotherapy, and photobiostimulation. The treatment resulted in 82.5% (33/40) of patients showing excellent outcomes and 17.5% (7/40) showing good results. The treatment showed an early clinical response after only four months, with results maintained over the following 12 to 18 months. A 20% increase in hair shaft diameter was observed. Side effects were mild and included pain after the mesotherapy session and itchy or burning sensation resolving within 24 hours. At the end of treatment, 97.5% (39/40) of patients reported high satisfaction with the treatment. The study concludes that the combination of SEFFIHAIR™ and TRICHOBIOLIGHT® is an effective treatment for AGA.